Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
Virafin from Zydus Cadila priced at Rs 11,995 per dose
The company has commenced dispatching the drug which can reportedly reduce oxygen support in COVID-19 patients, as per reports
States must ensure special teams to prevent black marketing of drugs: Centre to SC
The Centre said that the DCGI has instructed the state governments that there should be zero tolerance to any kind of hoarding or…
DCGI nod for anti-COVID 19 drug developed by DRDO
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental…
MSN Laboratories launches Favilow (Faripiravir) 800 mg tablets
The higher strength Favilow 800 mg is priced at Rs 144 per tablet and will be available across pharmacies
Zydus Cadila gets EUA from DCGI for hepatitis drug Virafin to treat COVID-19
When administered early on during COVID, Virafin will help patients recover faster and avoid much of the complications, informed…
Jubilant Pharma subsidiary announces development of novel oral formulation of Remdesivir
The proposed oral treatment is expected to be for five days
Dr Reddy’s receives EUA for Sputnik V in India
Sputnik V uses two different vectors for the two shots in a course of vaccination and its efficacy was determined to be 91.6 per…
Zydus seeks DCGI nod for Pegylated Interferon alpha-2b to treat COVID-19
91.15 per cent of patients treated with PegIFN were RT PCR negative by day 7 as compared to 78.90 per cent on the standard of care…
DCGI expert committee allows clinical trials for third dose of Bharat Biotech’s Covaxin
The committee recommended that the firm may unblind the participants of age group of more than 45 years and offer to administer…